Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) was down 10.7% on Monday . The company traded as low as $0.21 and last traded at $0.22. Approximately 2,151,500 shares traded hands during mid-day trading, an increase of 254% from the average daily volume of 608,350 shares. The stock had previously closed at $0.25.
Lexaria Bioscience Price Performance
The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.01 and a current ratio of 8.52. The business has a 50-day moving average price of $0.22.
About Lexaria Bioscience
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
Featured Stories
- Five stocks we like better than Lexaria Bioscience
- P/E Ratio Calculation: How to Assess Stocks
- The Average 401k Balance by Age Explained
- Insider Buying Explained: What Investors Need to Know
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
